Home >
Medicine Info >
Bimat LS TM Eye Drops
Loading interface...

Bimat LS TM Eye Drops

Manufactured byAJANTA PHARMA LTD
ContainsBimatoprost (0.01 %w/v) + Timolol (0.5 %w/v)
Description
Bimat LS TM Eye Drops is a combination medicine used for the treatment of increased eye pressure in patients suffering from open-angle glaucoma or ocular hypertension, conditions which may lead to eventual vision loss. This medicine is not recommended for use in patients less than 18 years of age.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Bimat LS TM Eye Drops

  • Blurred vision
  • Change in color vision
  • Eye color changes
  • Eye discharge
  • Headache
  • Burning or itching of eyes
  • Redness of the eye
  • Eye swelling
  • Eye pain
  • Dizziness

Uses of Bimat LS TM Eye Drops

What is it prescribed for?

  • Open angle Glaucoma
  • Intraocular hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 20 to 30 minutes of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition. If the medicine is used, monitor the infant closely for any adverse effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to bimatoprost, timolol or any other inactive ingredients present along with the formulation.

Respiratory diseases

This medicine is not recommended for use in patients with a known history of respiratory diseases such as bronchial asthma or severe chronic obstructive pulmonary disease due to the increased risk of worsening of the patient's condition.

Sinus Bradycardia

This medicine is not recommended for use in patients with a known history of sinus bradycardia due to the increased risk of worsening of the patient's condition.

Atrioventricular Block

This medicine is not recommended for use in patients with a known history of second or third degree AV block, not controlled with a pacemaker, due to the increased risk of worsening of the patient's condition.

Overt Cardiac Failure

This medicine is not recommended for use in patients with a known overt cardiac failure due to the increased risk of worsening of the patient's condition.

Cardiogenic shock

This medicine is not recommended for use in patients with a known history of cardiogenic shock due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition. If the medicine is used, monitor the infant closely for any adverse effects.
General warnings

Contact lens

This medicine is not recommended for use if you are wearing soft contact lenses in your eyes. The lens should be removed prior to administration of the eye drops and can be reinserted 15 minutes post administration.

Cardiac failure

This medicine should be used with extreme caution in patients with a known history of cardiac failure since it may worsen the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Use in children

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. In such a case, the patient should be monitored closely for any adverse effects.

Driving or operating machines

This medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Epinephrine

Beta blockers

Clonidine

Calcium antagonists

Catecholamine depleting agents

Digitalis

Latanoprost

Travoprost

Disease interactions

Macular edema

This medicine should be used with caution in patients with macular edema due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative may be required based on the clinical condition of the patient.

Uveitis

This medicine should be used with caution in patients with uveitis or active intraocular inflammation due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative may be required based on the clinical condition of the patient.

Diabetes

This medicine should be used with caution in patients with a known history of diabetes due to the increased risk of very low blood sugar levels. You may require a dose adjustment and more frequent monitoring of blood glucose levels to safely use this medicine. Replacement with a suitable alternative may be required in some cases based on the clinical condition.

Hyperthyroidism

This medicine should be used with caution in patients with a known history of hyperthyroidism since an abrupt withdrawal of therapy may worsen the patient's condition. Therapy should be discontinued gradually over a period of 1 to 2 weeks, when necessary, to decrease this risk. Replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Use this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by reducing the fluid pressure inside the eyes.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Ophthalmic glaucoma agents

Schedule

Schedule H

DailyMed - Bimatoprost solution/ drops [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 26 March 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27bef7e1-750a-4ac1-ab5f-e4c0121ffcbc

Timolol Ophthalmic: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 15 March 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a682043.html

Bimatoprost - DrugBank [Internet]. Drugbank.ca. 2019 [cited 24 April 2019]. Available from:

https://www.drugbank.ca/drugs/DB00905

Timolol - DrugBank [Internet]. Drugbank.ca. 2019 [cited 24 April 2019]. Available from:

https://www.drugbank.ca/drugs/DB00373
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 7 Jun 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.